MedTrace Logo

Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

NCT06268561 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2024-02-20

No results posted yet for this study

Summary

OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.

Conditions

  • Endophthalmitis

Interventions

OTHER

Visual acuity analysis

Collection of information on visual acuity from the medical file concerning the surgery

OTHER

Intraocular pressure analysis

Collection of information on intraocular pressure from the medical file concerning the surgery

OTHER

Analysis of optical coherence tomography (OCT) images

Collection and analysis of optical coherence tomography (OCT) images of the medical file concerning the surgery

OTHER

Analysis of retinograms

Collection and analysis of retinography images of the medical file concerning the surgery

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Thibaud GARCIN, MD PhD · CHU SAINT-ETIENNE

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-05
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06268561 on ClinicalTrials.gov